| Net Cash Provided by (Used in) Operating Activities |
$854,000,000 |
USD |
32% |
Q4 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$1,218,100,000 |
USD |
41% |
Q4 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$116,200,000 |
USD |
-104% |
Q4 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
1,000,000,000 |
shares |
0% |
Q4 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
404,464,668 |
shares |
0.3% |
Q4 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$480,300,000 |
USD |
67% |
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$2,553,000,000 |
USD |
-17% |
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$14,600,000 |
USD |
-2% |
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Gross |
$594,000,000 |
USD |
5% |
Q3 2025 |
FY 2025 |
| Operating Lease, Liability |
$68,900,000 |
USD |
32% |
Q4 2025 |
Q1 2026 |
| Payments to Acquire Property, Plant, and Equipment |
$27,400,000 |
USD |
106% |
Q4 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid |
$71,900,000 |
USD |
24% |
Q3 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$19,300,000 |
USD |
21% |
Q3 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$29,000,000 |
USD |
4.7% |
Q3 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$11,500,000 |
USD |
55% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$36,500,000 |
USD |
-6.2% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
30,000,000 |
shares |
0% |
Q4 2025 |
Q1 2026 |
| Unrecognized Tax Benefits |
$0 |
USD |
-100% |
Q3 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$6,800,000 |
USD |
70% |
Q3 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$27,700,000 |
USD |
15% |
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$579,400,000 |
USD |
5.2% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q4 2025 |
Q1 2026 |